Two Industry Leaders on the Growing Complexity of Genomic Cancer Data
Illumina Genomics Podcast
by Illumina Genomics Podcast
3M ago
In this podcast, Mendelspod’s Theral Timpson speaks to Cara Statz from JAX and Erica Schnettler from Illumina about how their combined technologies are helping researchers and oncologists deal with the increasing complexity of cancer genomic data. They discuss oncologists' experience dealing with an overwhelming amount of new scientific data, and both guests give their advice for new labs setting up cancer testing and oncology clinical research ..read more
Visit website
How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina's AI Lab, Kyle Farh
Illumina Genomics Podcast
by Illumina Genomics Podcast
3M ago
In this podcast, Mendelspod’s Theral Timpson speaks to Kyle Farh, VP and distinguished scientist leading Illumina’s Artificial Intelligence Lab. Farh says the company began the AI lab seven years ago when deep learning was just taking off. Two of the team’s AI algorithms, PrimateAI-3D and SpliceAI, published in Cell and Nature Genetics, were among the first examples of deep learning algorithms in genomics. This interview takes a close look at Illumina’s activities in AI and delves into the long-term impact of AI on genomics ..read more
Visit website
Illumina Scales Variant Calling and Genome Interpretation to Improve Gaps in Genetic Testing
Illumina Genomics Podcast
by Illumina Genomics Podcast
3M ago
In this podcast, Mendelspod’s Theral Timpson is joined by Sam Strom, a principal scientist at Illumina with a background in clinical testing. In this interview, Sam addresses two of the big challenges in clinical sequencing, which are variant calling and variant interpretation. Sam says Illumina has created its own multi-sample genomic reference and is also making use of artificial intelligence to improve variant calling. He also shares how Illumina supports scaling variant interpretation for genomes and other assays with an AI and automation comprehensive solution, enabling high-quality genet ..read more
Visit website
Clinical utility of ctDNA testing in lung cancer
Illumina Genomics Podcast
by Illumina Genomics Podcast
3M ago
Atocha Romero, PharmD, PhD, explains the value of liquid biopsy-based comprehensive genomic profiling. Dr. Romero provides an overview of the results of the NADIM II clinical trials and discusses ctDNA testing to monitor disease and guide treatment. Atocha Romero, PharmD, PhD, is the director of the Liquid Biopsy Laboratory of the Medical Oncology Department at the Hospital Universitario Puerta de Hierro in Madrid, Spain ..read more
Visit website
Does finding a rare mutation accomplish anything?
Illumina Genomics Podcast
by Illumina Genomics Podcast
3M ago
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute ..read more
Visit website
Liquid biopsy NGS in cancer care
Illumina Genomics Podcast
by Illumina Genomics Podcast
1y ago
Pashtoon Kasi, MD, MS, explains how liquid biopsy next-generation sequencing (NGS)-based testing can benefit cancer patients. Dr. Kasi presents four colorectal cancer patient cases for whom comprehensive genomic profiling (CGP) was done via liquid biopsy and results for clinically-relevant biomarkers were obtained in 7-8 days ..read more
Visit website
Genetic counselling in an era of prenatal screening, tools to support patient informed consent
Illumina Genomics Podcast
by Illumina Genomics Podcast
1y ago
Listen to Genetic Counsellors Katie Ellis and Patricia Winters, Illumina discuss how more resource-efficient counselling methods are needed to support patient informed consent for genetic testing during pregnancy. They discuss the resources available for healthcare providers and expectant parents that allows them to make informed decisions ..read more
Visit website
Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer
Illumina Genomics Podcast
by Illumina Genomics Podcast
1y ago
Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and BRCA status in ovarian cancer patients. She presents the case of a patient who benefited from CGP testing for these biomarkers and shares the recent findings of the PAOLA-1 trial ..read more
Visit website
Testing for NTRK Fusions
Illumina Genomics Podcast
by Illumina Genomics Podcast
1y ago
Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next generation sequencing (NGS)-based testing for NTRK gene fusions. He presents the case of a patient who benefited from precision medicine based on the detection of a NTRK1 fusion by comprehensive genomic profiling ..read more
Visit website
Pharmacogenomics: Barriers and Opportunities to Implementation
Illumina Genomics Podcast
by null
3y ago
Dr. Ronald Leopold discusses implementation of pharmacogenomic screening in the healthcare industry. The conversation explores barriers to pharmacogenomic (PGx) program adoption, the future of precision medicine, and a paradigm shift away from reimbursement to value-based healthcare ..read more
Visit website

Follow Illumina Genomics Podcast on FeedSpot

Continue with Google
Continue with Apple
OR